NCT05322850 2026-04-13
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
University of Florida
Phase 1/2 Suspended
University of Florida
SymBio Pharmaceuticals
Masonic Cancer Center, University of Minnesota
Insel Gruppe AG, University Hospital Bern
Myeloid Therapeutics
Northwestern University